Barreto Maria E S F, Lipay Mariana E, Santos Leandro D, Sirianni Marilia F Mascarenhas, Costa Thiago H, Castilho Lilian, Hamerschlak Nelson, Kutner José M, Bub Carolina B
Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, SP, Brazil.
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Hematol Transfus Cell Ther. 2021 Oct-Dec;43(4):489-493. doi: 10.1016/j.htct.2020.08.015. Epub 2020 Nov 4.
Low levels of neutrophils can be an intrinsic condition, with no clinical consequences or immunity impairment. This condition is the benign constitutional neutropenia (BCN), defined as an absolute neutrophils count (ANC) ≤2000 cells/mm. Diagnosis of BCN is of exclusion where patients are submitted to blood tests and possibly to invasive diagnostic search until secondary causes of neutropenia are ruled out. The natural history of the disease suggests benign evolution and Brazilian study showed an overall frequency of 2.59%. The main mechanisms include reduced neutrophil production, increased marginalization, extravasation to the tissues and immune destruction. Genetic studies showed strong association between the single nucleotide variant rs2814778 located on chromosome 1q23.2 in the promoter region of the atypical chemokine receptor 1 (Duffy blood group system) gene (ACKR1, also termed DARC) and BCN. The aim of this study is to evaluate FY phenotypes and genotypes including the analysis of the rs2814778 SNP in Brazilian patients with BCN in order to determine an effective diagnostic tool, allowing reassurance of the patient and cost reduction in their care.
Case control study, with 94 individuals (18 patients and 76 controls). Phenotyping was performed by gel test and genotyping was performed by PCR-RFLP.
White blood cell (WBC) and absolute neutrophils (AN) counts showed lower levels in patients compared to controls. In the patient group 83.3% were genotyped as FYB/FYB. The SNP rs2814778 (-67T > C) was identified in 77.8% of the patients genotyped as FYB-67C/FYB-67C. In the control group, 72.7% were homozygous for the wild type and 23.3% were heterozygous.
This study reinforces that FY phenotyping and genotyping can be used to detect most people with BCN, avoiding excessive diagnostic investigation. Besides, this procedure may reduce health costs and be reproductible in clinical practice.
中性粒细胞水平低可能是一种内在状况,无临床后果或免疫损害。这种情况即良性体质性中性粒细胞减少症(BCN),定义为绝对中性粒细胞计数(ANC)≤2000个细胞/mm³。BCN的诊断是排除性诊断,患者需进行血液检查,并可能进行侵入性诊断检查,直至排除中性粒细胞减少的继发原因。该疾病的自然病程提示为良性演变,巴西的一项研究显示其总体发生率为2.59%。主要机制包括中性粒细胞生成减少、边缘化增加、向组织外渗以及免疫破坏。基因研究表明,位于1号染色体1q23.2上非典型趋化因子受体1(达菲血型系统)基因(ACKR1,也称为DARC)启动子区域的单核苷酸变异rs2814778与BCN之间存在强关联。本研究的目的是评估巴西BCN患者的FY表型和基因型,包括对rs2814778单核苷酸多态性的分析,以确定一种有效的诊断工具,使患者安心,并降低其治疗成本。
病例对照研究,共94人(18例患者和76名对照)。通过凝胶试验进行表型分析,通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)进行基因分型。
与对照组相比,患者的白细胞(WBC)和绝对中性粒细胞(AN)计数较低。在患者组中,83.3%的基因型为FYB/FYB。在基因型为FYB-67C/FYB-67C的患者中,77.8%检测到单核苷酸多态性rs2814778(-67T>C)。在对照组中,72.7%为野生型纯合子,23.3%为杂合子。
本研究强化了FY表型分析和基因分型可用于检测大多数BCN患者,避免过度诊断性检查。此外,该方法可能降低医疗成本,且在临床实践中具有可重复性。